Abstract
Cancers impose an increasing burden on health of the populations and individuals, but little is known about cancer patient satisfaction with care. The aim of this study was to assess the psychometric properties of the Persian version of European Organisation for Research and Treatment of Cancer (EORTC) In-Patsat32, as a recently developed questionnaire to assess cancer patient satisfaction with care and information provided during hospital admission. Complying with EORTC protocols, the Persian version of Inpatsat32 was translated and piloted in a small group of patients, then applied to 380 cancer patients admitted to different oncology wards in Tehran. Validity (convergent, discriminant, and divergent) and reliability of the tool was assessed through using multitrait analysis, factor analysis, intraclass correlations, Chronbach's alpha and test-retest (on a sample of 70 patients). Good acceptance and high sensitivity of the questionnaire with low floor and ceiling effects were recognized, indicating power of the instrument to detect differences between groups with heterogeneous levels of satisfaction. Multitrait scaling analyses supported the convergent validity of the majority of scales (correlation coefficient >0.4) and favorable discriminant validity (item own scale correlation >0.8). There was no correlation between In-patsat32 scales and the EORTC-C30, which measures different concepts, confirming divergent validity of the tool. Internal consistency for all domains was high (α>0.70) except for the hospital access score and the test-retest reliability was excellent (r=0.86-0.96). There was a weak responsiveness to change except for nurses technical skills. Principle component analysis confirmed five domains with much improved internal consistency (α>0.9). The Persian version of the EORTC-in-patsat32 module is a reliable and valid instrument to measure cancer patient satisfaction with care received during their hospitalization period and can be utilized in clinical cancer research.
Highlights
During the past decades, cancer incidence and mortality rates had an increasing trend especially in less developed and economically transitioning countries (Jemal et al, 2010), which indicate 8 million death from cancer in 2010, 38% more than the past two decades (Lozano et al, 2013)
The aim of this study was to assess the psychometric properties of the Persian version of European Organisation for Research and Treatment of Cancer (EORTC) In-Patsat32, as a recently developed questionnaire to assess cancer patient satisfaction with care and information provided during hospital admission
A cross-sectional study was designed to assess satisfaction of cancer patients admitted to oncology wards in three public hospitals in Tehran (Hafte-tir, Firuzgar and cancer institute) over a period of three months starting in February 2013 to validate the Persian version of the EORTC-in-patsat32 questionnaire
Summary
Cancer incidence and mortality rates had an increasing trend especially in less developed and economically transitioning countries (Jemal et al, 2010), which indicate 8 million death from cancer in 2010, 38% more than the past two decades (Lozano et al, 2013). Good quality of health services influence patients satisfaction and their positive perception may lead to better adherence to care plans and satisfied patients are more likely to comply with treatment, which in turn affect treatment process (Asadi-Lari et al, 2004). The aim of this study was to assess the psychometric properties of the Persian version of European Organisation for Research and Treatment of Cancer (EORTC) In-Patsat, as a recently developed questionnaire to assess cancer patient satisfaction with care and information provided during hospital admission. Conclusions: The Persian version of the EORTC-in-patsat module is a reliable and valid instrument to measure cancer patient satisfaction with care received during their hospitalization period and can be utilized in clinical cancer research
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
